“In Silico Design, ADMET Prediction and Molecular Docking Studies of Novel Cyanopyridine-Substituted 1,3,5-Triazine Derivatives As Potential Anti-Alzheimer Agents”. 2026. MEDICARE CHURNING International Journal of Medical Science, Healthcare & Research Innovations 1 (2): 16-39. https://doi.org/10.5281/zenodo.21498307.